Skip to main content
Category

Cancer Program

Breast CancerCancer and Cell BiologyCancer EpigeneticsDisease AreaLabNews & EventsResearchResearch Area

Personalised medicine using nanoparticles for breast cancer treatment

By | Breast Cancer, Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research Area

At the Harry Perkins Institute of Medical Research, a Cancer Epigenetics team is investigating ways to leverage the great opportunities that nanotechnology offers in the treatment of one of the…

CellsDisease AreaLabMolecular MedicineNews & EventsResearchResearch AreaSynthetic Biology and Drug Discovery

Molecular machines stop cancer’s clock

By | Cells, Disease Area, Lab, Molecular Medicine, News & Events, Research, Research Area, Synthetic Biology and Drug Discovery

Head of the laboratory for Synthetic Biology and Drug Discovery, Professor Oliver Rackham, says cancer cells grow uncontrollably whereas normal cells limit their growth. “A normal cell grows for just the…

Cancer and Cell BiologyCancer EpigeneticsDisease AreaLabNews & EventsResearchResearch AreaTumours

Perkins researchers turn on cancer killing genes

By | Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research Area, Tumours

Dr Benjamin Garcia Bloj, along with his labmates from the Perkins Cancer Epigenetics Laboratory headed by Associate Professor Pilar Blancafort, used a gene-editing technology called CRISPR to ‘wake up’ key tumour suppressors to…

Disease AreaHeartLabMitochondrial Medicine and BiologyMolecular MedicineNews & EventsResearchResearch AreaSynthetic Biology and Drug Discovery

Perkins researchers find essential gene for healthy hearts

By | Disease Area, Heart, Lab, Mitochondrial Medicine and Biology, Molecular Medicine, News & Events, Research, Research Area, Synthetic Biology and Drug Discovery

Professor Aleksandra Filipovska and her team from the Perkins Mitochondrial Medicine and Biology Laboratory in collaboration with Professor Oliver Rackham and Professor Nils Göran Larsson and his team from the Max Planck Institute for Biology…